PHS
PARA

PFM Health Sciences’s Paramount Global Class B PARA Stock Holding History

PFM Health Sciences’s Portfolio PARA Stock Details PARA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-756,160
Closed -$47M – 69
2014
Q2 		$47M Sell
756,160
-412,496
-35% -$24.6M 0.94% 36
2014
Q1 		$72.2M Buy
1,168,656
+517,688
+80% +$32.7M 1.31% 28
2013
Q4 		$41.5M Sell
650,968
-1,684,644
-72% -$99.1M 0.83% 35
2013
Q3 		$129M Sell
2,335,612
-694,531
-23% -$37M 3.1% 10
2013
Q2 		$148M Buy
+3,030,143
New +$138M 3.08% 9

Other funds holding PARA

Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
WRF
Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
SCP
Soroban Capital Partners New York $51.8B AUM 21.41% 1-Year Est. Return

PFM Health Sciences's PARA Position: Q3 2014 in Review

PFM Health Sciences sold out of Paramount Global Class B (PARA) in Q3 2014, closing a stake of 756,160 shares — an estimated $47M sold.

PFM Health Sciences first reported a position in PARA in Q2 2013 and held it in 5 quarters. The position peaked at $148M in Q2 2013. 649 funds tracked by Wall St. Rank hold PARA as of Q3 2014.

  • PFM Health Sciences reported no remaining Paramount Global Class B position as of Q3 2014 after selling out during the quarter.
  • PFM Health Sciences sold 756,160 Paramount Global Class B shares in Q3 2014, an estimated $47M.
  • PFM Health Sciences first reported a position in Paramount Global Class B in Q2 2013 and held it in 5 quarters.
  • PFM Health Sciences's Paramount Global Class B position peaked at $148M in Q2 2013.
  • 649 funds tracked by Wall St. Rank held Paramount Global Class B as of Q3 2014.

Based on PFM Health Sciences's 13F filing for Q3 2014, filed 14 Nov 2014.